Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xiangle Zeng, Yawen Zhang, Xue Xu, Zhuo Chen, Lanlan Ma, Yushuai Wang, Xuliang Guo, Jianchun Li & Xiu Wang. (2022) Construction of pH-sensitive targeted micelle system co-delivery with curcumin and dasatinib and evaluation of anti-liver cancer. Drug Delivery 29:1, pages 792-806.
Read now
Read now
Hairong Wang, Yawen Zhang, Xiangle Zeng, Wenjun Pei, Ranran Fan, Yushuai Wang, Xiu Wang & Jianchun Li. (2021) A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy. International Journal of Nanomedicine 16, pages 2373-2388.
Read now
Read now
Nanxin Li, Xi Yang, Liangyi Fan, Todor Totev, Annie Guerin, Lei Chen, Subrata Bhattacharyya & George Joseph. (2017) Nilotinib versus dasatinib as second-line therapy in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who are resistant or intolerant to imatinib: a cost-effectiveness analysis based on real-world data. Journal of Medical Economics 20:4, pages 328-336.
Read now
Read now
Dominick Latremouille-Viau, Annie Guerin, Roy Nitulescu, Patrick S. Gagnon, George J. Joseph & Lei Chen. (2017) Treatment patterns and healthcare costs among newly-diagnosed patients with chronic myeloid leukemia receiving dasatinib or nilotinib as first-line therapy in the United States. Journal of Medical Economics 20:1, pages 63-71.
Read now
Read now
Francesca Musumeci, Silvia Schenone, Giancarlo Grossi, Chiara Brullo & Monica Sanna. (2015) Analogs, formulations and derivatives of imatinib: a patent review. Expert Opinion on Therapeutic Patents 25:12, pages 1411-1421.
Read now
Read now
Articles from other publishers (4)
Yan Xia, Miao Feng, Erkang Wang, Li Chen, Jin Wang, Ruibin Hou & Yinping Zhao. (2019)
An
ent
‐Kaurane Diterpenoid Isolated from
Rabdosia excisa
Suppresses Bcr‐Abl Protein Expression
in Vitro
and
in Vivo
and Induces Apoptosis of CML Cells
. Chemistry & Biodiversity 16:10.
Crossref
Crossref
Natalia Papadopoulos & Johan Lennartsson. (2018) The PDGF/PDGFR pathway as a drug target. Molecular Aspects of Medicine 62, pages 75-88.
Crossref
Crossref
Fen Zhou, Runming Jin, Yu Hu & Heng Mei. (2017) A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case. Molecular Cytogenetics 10:1.
Crossref
Crossref
Nisintha Mahendrarajah, Ramin Paulus & Oliver H. Krämer. (2016) Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells. Journal of Cancer Research and Clinical Oncology 142:11, pages 2263-2273.
Crossref
Crossref